GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+16.18%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.27B
AUM Growth
+$1.27B
(+15%)
Cap. Flow
+$7.5M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
32.1%
Holding
194
New
16
Increased
57
Reduced
67
Closed
2
Top Buys
| 1 |
Unilever
UL
|
$13.7M |
| 2 |
RTX Corp
RTX
|
$5.97M |
| 3 |
Hexcel
HXL
|
$3.32M |
| 4 |
Chevron
CVX
|
$1.35M |
| 5 |
US Bancorp
USB
|
$1.31M |
Top Sells
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
$13.3M |
| 2 |
Microsoft
MSFT
|
$2.28M |
| 3 |
PayPal
PYPL
|
$2.19M |
| 4 |
eBay
EBAY
|
$1.88M |
| 5 |
Autodesk
ADSK
|
$1.07M |
Sector Composition
| 1 | Technology | 28.26% |
| 2 | Healthcare | 15.73% |
| 3 | Financials | 12.71% |
| 4 | Industrials | 12.19% |
| 5 | Consumer Staples | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zimmer Biomet
ZBH
$21B
| $19.8M | 1.56% |
128,664
-370
| -0.3% | -$57K |
|
27
Applied Materials
AMAT
$128B
| $19.8M | 1.55% |
228,826
-6,855
| -3% | -$592K |
|
|
28
US Bancorp
USB
$76B
| $19.6M | 1.53% |
419,898
+28,059
| +7% | +$1.31M |
|
29
Chubb
CB
$110B
| $19.5M | 1.53% |
126,412
+5,225
| +4% | +$804K |
|
30
Procter & Gamble
PG
$368B
| $17.2M | 1.35% |
123,890
-2,914
| -2% | -$406K |
|
31
Brunswick
BC
$4.15B
| $16.6M | 1.3% |
218,177
-175
| -0.1% | -$13.3K |
|
32
PPG Industries
PPG
$25.1B
| $16.4M | 1.28% |
113,473
+1,640
| +1% | +$237K |
|
33
Johnson & Johnson
JNJ
$427B
| $16.1M | 1.26% |
102,265
+2,979
| +3% | +$469K |
|
|
34
RTX Corp
RTX
$212B
| $15.6M | 1.23% |
218,614
+83,503
| +62% | +$5.97M |
|
35
Sanofi
SNY
$121B
| $15.2M | 1.19% |
312,944
+8,885
| +3% | +$432K |
|
36
Apple
AAPL
$3.45T
| $14.4M | 1.13% |
108,418
-4,340
| -4% | -$576K |
|
37
John Wiley & Sons Class A
WLY
$2.16B
| $14.2M | 1.11% |
310,943
+16,287
| +6% | +$744K |
|
38
Cognizant
CTSH
$35.3B
| $13.8M | 1.08% |
167,813
+1,430
| +0.9% | +$117K |
|
39
M&T Bank
MTB
$31.5B
| $12.6M | 0.99% |
98,640
-7,283
| -7% | -$927K |
|
40
Novartis
NVS
$245B
| $12.4M | 0.97% |
131,318
-580
| -0.4% | -$54.8K |
|
41
Corning
GLW
$57.4B
| $12.3M | 0.96% |
340,617
-1,740
| -0.5% | -$62.6K |
|
42
Gilead Sciences
GILD
$140B
| $10.8M | 0.85% |
185,980
+3,370
| +2% | +$196K |
|
|
43
Chevron
CVX
$324B
| $10.5M | 0.82% |
123,934
+15,945
| +15% | +$1.35M |
|
44
Thermo Fisher Scientific
TMO
$186B
| $10.4M | 0.81% |
22,256
-1,224
| -5% | -$570K |
|
|
FLIR
45
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $9.95M | 0.78% |
226,943
+27,400
| +14% | +$1.2M |
|
|
46
Hexcel
HXL
$5.02B
| $9.09M | 0.71% |
187,510
+68,467
| +58% | +$3.32M |
|
47
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.58M | 0.67% |
17,755
+1,085
| +7% | +$524K |
|
48
Mondelez International
MDLZ
$79.5B
| $7.73M | 0.61% |
132,197
-471
| -0.4% | -$27.5K |
|
49
Berkshire Hathaway Class A
BRK.A
$1.09T
| $7.65M | 0.6% |
22
| – | – |
|
|
RDS.B
50
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $7.37M | 0.58% |
219,383
-8,488
| -4% | -$285K |
|